Plant Comparison

Water Hyssop vs Saffron

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AWater HyssopBacopa monnieriPlantaginaceaeFull monograph →
Plant BSaffronCrocus sativusIridaceaeFull monograph →

At a glance

Water Hyssop and Saffron: they share 7 indicated uses (arthritis / joint pain, cancer (anticancer research), cognitive function, …); 5 pharmacological actions in common.

Water HyssopSaffron
Constituents23
Pharmacological actions56
Indicated uses710
Safety notes22
Cited sources2026
Indicated uses
Only Water Hyssop
none
Shared (7)
Arthritis / joint painCancer (anticancer research)Cognitive functionInflammation (general)Insomnia / sleeplessnessMemorySkin irritation
Only Saffron
Blood sugar / diabetes supportMenstrual crampsMetabolic support
Pharmacological actions
Only Water Hyssop
none
Shared (5)
Anti-inflammatoryAnticancer (preclinical)AntioxidantNeuroprotective / cognition supportSedative / sleep support
Only Saffron
Antidiabetic (blood-sugar lowering)

Evidence face-off — shared uses

ConditionWater HyssopSaffronVerdict
Arthritis / joint pain1/101/10Comparable evidence
Cancer (anticancer research)2/108/10Stronger for Saffron
Cognitive function6/101/10Stronger for Water Hyssop
Inflammation (general)1/101/10Comparable evidence
Insomnia / sleeplessness1/101/10Comparable evidence
Memory6/101/10Stronger for Water Hyssop
Skin irritation1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Triterpenoid saponins (bacosides A and B)[1, 4]

Principal bioactive saponins linked to the plant's neuroprotective and cognition-enhancing effects.

SaponinsTriterpene saponins
Flavonoids and alkaloids[6]

Additional antioxidant and neuroactive constituents.

FlavonoidsAlkaloids
Crocin and crocetin[1]

Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.

CrocinCrocetin
Safranal[1]

The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.

Safranal
Picrocrocin

The main bitter-tasting glycoside of the stigma, a precursor of safranal.

Picrocrocin

Pharmacological Actions

Anti-inflammatory[9, 13]
Anticancer (preclinical)[3, 14, 15]

Bacopa monnieri (Brahmi) extract and its saponins (bacopaside II, bacopasaponins) inhibit proliferation and induce apoptosis in colon and lung cancer cells (preclinical).

Antioxidant[6, 8, 9, 13]
Neuroprotective / cognition support[1, 3, 4, 5, 6, 7, 10, 13, 16, 17]
Sedative / sleep support[1, 13]
Anti-inflammatory[7, 9, 14, 15, 16]
Anticancer (preclinical)[10, 11, 14, 15, 16]
Antidiabetic (blood-sugar lowering)[14, 15, 16]
Antioxidant[8, 9, 14, 15, 16]
Neuroprotective / cognition support[8, 12, 14, 15, 16]
Sedative / sleep support[2, 4, 5, 6, 13, 14, 15, 16]

Traditional & Indicated Uses

Arthritis / joint pain[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[3, 14, 15]Traditional · 2/10

Bacopaside II from Bacopa monnieri inhibits colon cancer cell growth via cell-cycle arrest and apoptosis (aquaporin-1 blockade), and its bacopasaponins are cytotoxic to lung (PC9) and colon (SW620) cancer cells (preclinical).

Evidence: 2
Label: Cancer (anticancer research)
Cognitive function[13, 16, 17]Moderate · 6/10

inferred from neuroprotective action

Evidence: 6
Label: Cognitive function
Inflammation (general)[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Insomnia / sleeplessness[13]Traditional · 1/10

inferred from sedative action

Evidence: 1
Label: Insomnia / sleeplessness
Memory[13, 16, 17]Moderate · 6/10

inferred from neuroprotective action

Evidence: 6
Label: Memory
Skin irritation[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Arthritis / joint pain[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Blood sugar / diabetes support[14, 15, 16]Traditional · 1/10

inferred from antidiabetic action

Evidence: 1
Label: Blood sugar / diabetes support
Cancer (anticancer research)[10, 11]Good · 8/10

inferred from anticancer action

Evidence: 8
Label: Cancer (anticancer research)
Cognitive function[14, 15, 16]Traditional · 1/10

inferred from neuroprotective action

Evidence: 1
Label: Cognitive function
Inflammation (general)[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Insomnia / sleeplessness[14, 15, 16]Traditional · 1/10

inferred from sedative action

Evidence: 1
Label: Insomnia / sleeplessness
Memory[14, 15, 16]Traditional · 1/10

inferred from neuroprotective action

Evidence: 1
Label: Memory
Menstrual cramps[14, 15, 16]Traditional · 1/10
Evidence: 1
Label: Menstrual cramps
Metabolic support[14, 15, 16]Traditional · 1/10

inferred from antidiabetic action

Evidence: 1
Label: Metabolic support
Skin irritation[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation

Safety, Cautions & Contraindications

Safety note[13, 16, 17]Caution

Generally well tolerated at standard doses. The most commonly reported side effects are gastrointestinal — nausea, stomach cramps, and increased bowel movements — which can be reduced by taking with food. Not recommended during pregnancy. May interact with medications that increase acetylcholine levels (e.g. Alzheimer's medications). Use with caution in thyroid conditions, as bacopa may increase thyroid hormone levels.

Safety note[13, 16, 17, 18]Info

Duke (2002) does not include a dedicated entry for Bacopa monnieri (water hyssop/brahmi) in the Handbook of Medicinal Herbs, Second Edition.

Safety note[14, 15, 16]Caution

Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.

Safety note[14, 15, 16, 17]Caution

Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).

External Ids

Gbif: 3171169
Wikidata: Q1366575
Gbif: 2747430
Powo: urn:lsid:ipni.org:names:436688-1
Wikidata: Q15041677

Botanical Description

Low, creeping, succulent perennial herb that roots at the nodes as it spreads across wet ground. The leaves are small, fleshy, spatula-shaped and arranged oppositely along the trailing stems. Small, pale lavender to white, four- to five-petalled flowers are borne singly in the leaf axils.[4]

Height: 5-15 cm (trailing/creeping)
Habit: Low, creeping, succulent perennial herb
Leaves: Small, fleshy, spatula-shaped, opposite
Flowers: Small, pale lavender to white, four- to five-petalled, borne singly in leaf axils
Stem: Trailing, succulent, rooting at the nodes
Root: Fine roots at each node along the creeping stem
Fruit: Small ovoid capsule
Flowering Period: Year-round in warm, wet climates

Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.

Height: 10-20 cm
Habit: Small, cormous, autumn-flowering perennial
Leaves: Narrow, grass-like, dark green, emerging with or just after the flowers
Flowers: Lilac-purple, six-petalled, with three golden anthers and three long deep-red stigma threads
Stem: Very short; flowers arise almost directly from the corm
Root: Underground corm with fibrous roots
Fruit: Sterile triploid; does not set seed, propagated by corm division
Flowering Period: Autumn (October-November)

Habitat

Grows in wet, marshy ground, muddy shorelines, rice paddies and shallow water throughout tropical and subtropical regions of Asia, and also found in parts of Africa, Australia and the Americas.[4]

Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.

Harvesting

The whole plant (leaf and trailing stem) is harvested during active growth, typically cut a few centimetres above the mud or water line, and dried or used fresh.

Parts: Leaf, Whole Plant
Season: During active growth (warm season)

The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.

Parts: Flower
Season: Autumn, at flowering, harvested at dawn

Traditional Uses

Bacopa (brahmi) is a classic Ayurvedic 'medhya rasayana' (brain-nourishing) herb, traditionally used to support memory, learning and mental clarity, and as a calming nervine for anxiety and disturbed sleep. This traditional cognitive reputation is now supported by randomised controlled trials of standardised extracts.[1, 4]

Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]

Preparations

Standardised extract[1, 4]

Extract standardised to bacoside content, taken as capsules or tablets; the form used in most clinical trials for cognitive support.

Standardised extract[1]

Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.

Dosage

Standardised extract[1, 4]

Clinical trials for cognitive support commonly use extracts providing around 300 mg dried extract daily, taken for at least several weeks, since benefits accrue gradually. Educational reference only, not a prescription.

Standardised extract[1]

Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.

References

REF-0740, REF-0741, REF-0742, REF-2107, REF-2108, REF-2109, REF-2110, REF-2111, REF-2112, REF-2113, REF-2114, REF-2115
REF-0788, REF-0789, REF-0790, REF-2001, REF-2002, REF-2003, REF-2004, REF-2005, REF-2006, REF-2007, REF-2008, REF-2009, REF-2010

Drug Class Interactions

Safety note[19, 20]Caution
Drug Class: sedatives-cns-depressants
Mechanism: Bacopa (brahmi) is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[18, 19]Caution
Drug Class: antidepressants-serotonergic
Mechanism: Saffron has antidepressant, serotonin-related activity (a meta-analysis of randomised trials found saffron more effective than placebo and comparable to standard antidepressants for mild-to-moderate depression; a trial safely combined low-dose saffron with SSRIs); because both raise serotonergic activity, combining saffron with antidepressants may add to serotonergic effects, so watch for side effects such as agitation or restlessness.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[20, 21]Caution
Drug Class: sedatives-cns-depressants
Mechanism: Saffron is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[22]Caution
Drug Class: antidiabetics
Mechanism: Saffron lowers fasting blood glucose and HbA1c in trials in people with diabetes; combined with diabetes medicines it may add to blood-sugar lowering, so monitor blood sugar.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: has-lookalikes
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dangerous Lookalikes

Not documented

Safety note[23, 24, 25, 26]Fatal
Dangerous Plant: colchicum-autumnale
Confused Part: The whole autumn flower (a leafless lilac-purple, crocus-shaped bloom) and its style/stigma threads that can be taken for saffron, plus the corm; in spring the strap-shaped leaves are also confused with other greens.
Confusion Context: Autumn crocus / meadow saffron (Colchicum autumnale, family Colchicaceae) flowers in autumn with a leafless lilac-purple crocus-like flower that closely mimics true saffron crocus (Crocus sativus, Iridaceae) and is even nicknamed 'meadow saffron'. It contains colchicine, a cell toxin with no readily available antidote; ingestion causes deceptively delayed (hours later) multi-organ failure and can be fatal. A Swiss poison-centre review lists it among the few plants that can kill (Kupper & Reichert 2009), and a documented case describes severe multi-organ injury after it was eaten in error (Gabrscek et al. 2004). University extensions warn it should definitely not be used in place of saffron, because eating any part of it can be fatal.
Distinguishing Features: STAMEN COUNT (decisive): true saffron crocus has exactly THREE stamens per flower; autumn crocus (Colchicum) has SIX. Two independent university extensions confirm three-versus-six as the hard, countable difference., SAFFRON THREADS: saffron crocus has one style splitting into three long, deep-RED branched stigmas (the saffron threads). Colchicum has three separate pale styles with yellow anthers and does not produce the long red saffron threads., FLOWER ARCHITECTURE: saffron crocus is in the iris family (Iridaceae; 3 stamens, 1 style); Colchicum is in Colchicaceae (6 stamens, 3 styles) - a fundamentally different flower.
Key Test: Count the stamens inside the open flower: exactly THREE (with three long deep-red saffron threads) = true saffron crocus. SIX stamens (pale styles, yellow anthers, no red threads) = autumn crocus (Colchicum) - do NOT eat or use as saffron; it can be fatal. If in any doubt, do not harvest.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Calabrese, C., Gregory, W.L., Leo, M., Kraemer, D. et al (2008) 'Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial', Journal of Alternative and Complementary Medicine, 14(6), pp. 707-713. doi:10.1089/acm.2008.0018 Randomized trial
    https://doi.org/10.1089/acm.2008.0018
  2. Lorca, C., Mulet, M., Arévalo-Caro, C., Sanchez, M.Á. et al (2022) 'Plant-derived nootropics and human cognition: A systematic review', Critical Reviews in Food Science and Nutrition, 63(22), pp. 5521-5545. doi:10.1080/10408398.2021.2021137 Meta-analysis / review
    https://doi.org/10.1080/10408398.2021.2021137
  3. Fatima, U., Roy, S., Ahmad, S., Ali, S. et al (2022) 'Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation', Frontiers in Nutrition, 9, pp. 972379. doi:10.3389/fnut.2022.972379 Traditional / reference
    https://doi.org/10.3389/fnut.2022.972379
  4. Kongkeaw, C., Dilokthornsakul, P., Thanarangsarit, P., Limpeanchob, N. and Norman Scholfield, C (2014) 'Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract', Journal of Ethnopharmacology, 151(1), pp. 528-535. doi:10.1016/j.jep.2013.11.008 Meta-analysis / review
    https://doi.org/10.1016/j.jep.2013.11.008
  5. Vinod, A., Sathianarayanan, S., Babu, A.E., Sadanandan, P., Venu, A.K. and Venkidasamy, B (2022) 'Bacopa monnieri for disorders affecting brain: current perspectives', Current Topics in Medicinal Chemistry, 22(23), pp. 1909-1929. doi:10.2174/1568026622666220119111538 Meta-analysis / review
    https://doi.org/10.2174/1568026622666220119111538
  6. Dubey, T., Kushwaha, P., Thulasiram, H.V., Chandrashekar, M. and Chinnathambi, S (2023) 'Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells', International Journal of Biological Macromolecules, 234, pp. 123171. doi:10.1016/j.ijbiomac.2023.123171 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2023.123171
  7. Shalini, V.T., Neelakanta, S.J. and Sriranjini, J.S (2021) 'Neuroprotection with Bacopa monnieri - a review of experimental evidence', Molecular Biology Reports, 48(3), pp. 2653-2668. doi:10.1007/s11033-021-06236-w Meta-analysis / review
    https://doi.org/10.1007/s11033-021-06236-w
  8. Simpson, T., Pase, M. and Stough, C (2015) 'Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain', Evidence-Based Complementary and Alternative Medicine, 2015, pp. 615384. doi:10.1155/2015/615384 Meta-analysis / review
    https://doi.org/10.1155/2015/615384
  9. Saini, N., Singh, D. and Sandhir, R (2019) 'Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action', Metabolic Brain Disease, 34(2), pp. 505-518. doi:10.1007/s11011-018-0332-1 Preclinical
    https://doi.org/10.1007/s11011-018-0332-1
  10. Dubey, T. and Chinnathambi, S (2019) 'Brahmi (Bacopa monnieri): an ayurvedic herb against the Alzheimer's disease', Archives of Biochemistry and Biophysics, 676, pp. 108153. doi:10.1016/j.abb.2019.108153 Meta-analysis / review
    https://doi.org/10.1016/j.abb.2019.108153
  11. Bhandari, P., Kumar, N., Singh, B. and Kaul, V.K (2007) 'Cucurbitacins from Bacopa monnieri', Phytochemistry, 68(9), pp. 1248-1254. doi:10.1016/j.phytochem.2007.03.013 Preclinical
    https://doi.org/10.1016/j.phytochem.2007.03.013
  12. Sivaramakrishna, C., Rao, C.V., Trimurtulu, G., Vanisree, M. and Subbaraju, G.V (2005) 'Triterpenoid glycosides from Bacopa monnieri', Phytochemistry, 66(23), pp. 2719-2728. doi:10.1016/j.phytochem.2005.09.016 Preclinical
    https://doi.org/10.1016/j.phytochem.2005.09.016
  13. World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  14. Smith, E. and Palethorpe, H.M. and Tomita, Y. and Pei, J.V. and Townsend, A.R. and Price, T.J. and Young, J.P. and Yool, A.J. and Hardingham, J.E (2018) 'The Purified Extract from the Medicinal Plant Bacopa monnieri, Bacopaside II, Inhibits Growth of Colon Cancer Cells In Vitro by Inducing Cell Cycle Arrest and Apoptosis', Cells, 7(7), pp. 81. doi:10.3390/cells7070081 Preclinical
    https://doi.org/10.3390/cells7070081
  15. Yen, D.T.H. and Cuc, N.T. and Tai, B.H. and Van Kiem, P. and Hoang Duc, M. and Nhiem, N.X. and Cho, S.-H. and Jeong, S.B. and Seo, Y. and Park, S (2022) 'Two new triterpenoid glycosides from Bacopa monnieri and their cytotoxic activity', Natural Product Research, 38(7), pp. 1120-1126. doi:10.1080/14786419.2022.2132498 Preclinical
    https://doi.org/10.1080/14786419.2022.2132498
  16. Calabrese, C., Gregory, W.L., Leo, M., Kraemer, D., Bone, K. and Oken, B (2008) 'Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly', 14(6), pp. 707--713. Randomized trial
    https://scholar.google.com/scholar?q=Effects%20of%20a%20standardized%20Bacopa%20monnieri%20extract%20on%20cognitive%20performance%2C%20anxiety%2C%20and%20depression%20in%20the%20elderly
  17. Stough, C., Lloyd, J., Clarke, J., Downey, L.A., Hutchison, C.W., Rodgers, T. and Nathan, P.J (2001) 'The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects', 156(4), pp. 481--484. doi:10.1007/s002130100815 Randomized trial
    https://doi.org/10.1007/s002130100815
  18. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  19. Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
    https://doi.org/10.1002/ptr.8201
  20. Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
    https://doi.org/10.1177/1534735404265003
  1. Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
    https://doi.org/10.1093/nutrit/nuae076
  2. Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
    https://doi.org/10.1002/hup.2434
  3. Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
    https://doi.org/10.1016/j.jep.2022.115719
  4. Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
    https://doi.org/10.3736/jintegrmed2013056
  5. Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
    https://doi.org/10.1016/j.ctim.2017.06.001
  6. Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
    https://doi.org/10.1089/cap.2018.0146
  7. Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
    https://doi.org/10.1055/s-0034-1375681
  8. Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
    https://doi.org/10.1021/acs.jafc.6b04398
  9. Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
    https://doi.org/10.1002/ptr.5622
  10. Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
    https://doi.org/10.1016/j.jtcme.2014.10.009
  11. Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
    https://doi.org/10.1016/j.phymed.2018.03.041
  12. El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
    https://doi.org/10.3390/nu14030597
  13. Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
    https://doi.org/10.3390/molecules26051237
  14. Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
    https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L
  15. Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
    https://scholar.google.com/scholar?q=Avicenna
  16. Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
    https://scholar.google.com/scholar?q=Crocus%20sativus%20L
  17. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  18. Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
    https://doi.org/10.1016/j.jad.2014.11.035
  19. Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
    https://doi.org/10.1055/a-0660-9565
  20. Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
    https://doi.org/10.1002/ptr.8201
  21. Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
    https://doi.org/10.1177/1534735404265003
  22. Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
    https://doi.org/10.3389/fnut.2024.1349006
  23. Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
    https://doi.org/10.1024/0040-5930.66.5.343
  24. Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
    https://doi.org/10.1081/clt-120028750
  25. University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
    https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/
  26. Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
    https://bygl.osu.edu/node/1458

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.